1-2 of 2
Aranzazu Manzano
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/MINOVA Study)

Beatriz Tavira, Teresa Iscar, Luis Manso, Ana Santaballa, Marta Gil-Martin, Yolanda García García, Margarita Romeo, Maria Iglesias, Ana de Juan Ferré, María Pilar Barretina-Ginesta, Aranzazu Manzano, Lydia Gaba, María Jesús Rubio, Carlos E. de Andrea, Antonio González-Martín
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (1): 176–186.
https://doi.org/10.1158/1078-0432.CCR-23-0771
Published: 05 January 2024
View articletitled, Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/MINOVA Study)
Open the PDF for Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/MINOVA Study) in another window
Includes: Supplementary data
Journal Articles

Inhibition of BET Bromodomain Proteins with GS-5829 and GS-626510 in Uterine Serous Carcinoma, a Biologically Aggressive Variant of Endometrial Cancer

Elena Bonazzoli, Federica Predolini, Emiliano Cocco, Stefania Bellone, Gary Altwerger, Gulden Menderes, Luca Zammataro, Anna Bianchi, Francesca Pettinella, Francesco Riccio, Chanhee Han, Ghanshyam Yadav, Salvatore Lopez, Aranzazu Manzano, Paola Manara, Natalia Buza, Pei Hui, Serena Wong, Babak Litkouhi, Elena Ratner, Dan-Arin Silasi, Gloria S. Huang, Masoud Azodi, Peter E. Schwartz, Joseph Schlessinger, Alessandro D. Santin
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (19): 4845–4853.
https://doi.org/10.1158/1078-0432.CCR-18-0864
Published: 01 October 2018
View articletitled, Inhibition of BET Bromodomain Proteins with GS-5829 and GS-626510 in Uterine Serous Carcinoma, a Biologically Aggressive Variant of Endometrial Cancer
Open the PDF for Inhibition of BET Bromodomain Proteins with GS-5829 and GS-626510 in Uterine Serous Carcinoma, a Biologically Aggressive Variant of Endometrial Cancer in another window
Includes: Supplementary data